Interleukin-21
| GO Term | Evidence Code | Reference |
|---|---|---|
| natural killer cell differentiation |
|
|
| positive regulation of cytokine production | ||
| positive regulation of cytokine production | ||
| positive regulation of cytokine production | ||
| germinal center B cell differentiation |
| GO Term | Evidence Code | Reference |
|---|---|---|
| extracellular region | ||
| extracellular region | ||
| extracellular region | ||
| obsolete extracellular space |
|
|
| GO Term | Evidence Code | Reference |
|---|---|---|
| cytokine activity |
|
|
| cytokine receptor binding | ||
| cytokine receptor binding | ||
| interleukin-2 receptor binding |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 97 |
|
|
| Pathway Name | Organism |
|---|---|
| Interleukin-21 signaling | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:9074 | systemic lupus erythematosus | |
| DOID:2841 | asthma | |
| DOID:684 | hepatocellular carcinoma | |
| DOID:0081153 | common variable immunodeficiency 11 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026